E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/28/2008 in the Prospect News PIPE Daily.

New Issue: China Pharma wraps $10 million private placement of shares

By Devika Patel

Knoxville, Tenn., May 28 - China Pharma Holdings Inc. completed a $10 million private placement of stock on May 27, according to an 8-K filed Wednesday with the Securities and Exchange Commission.

The company sold 5 million common shares at $2.00 per share, along with three-year warrants for 1.25 million common shares, each exercisable at $2.80.

Roth Capital Partners, LLC was the placement agent.

Located in Haikou City, China, China Pharma develops Western and Chinese medicines to treat infections, hepatitis, vascular diseases and other diseases.

Issuer:China Pharma Holdings Inc.
Issue:Common stock
Amount:$10 million
Shares:5 million
Price:$2.00
Warrants:For 1.25 million shares
Warrant expiration:Three years
Warrant strike price:$2.80
Agent:Roth Capital Partners, LLC
Settlement date:May 27
Stock symbol:OTCBB: CPHI
Stock price:$2.29 at close May 27

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.